Saxagliptin hydrate
- N ° de catalogue:A845005
- N ° CAS. : 945667-22-1
- Formule moléculaire:C18H27N3O3
- Masse moléculaire: 333.43
Remarque*
1. Please click the to confirm the discount and stock quantity.
2. Click“Bulk Inquiry”to ask for quotations of other quantity.
3. The price does not include shipping and bank charges.
Enquête en vrac
1. Please click the to confirm the discount and stock quantity.
2. Click“Bulk Inquiry”to ask for quotations of other quantity.
3. The price does not include shipping and bank charges.
Contrôle de qualité&SDS
détails du produit
Numero CAS | 945667-22-1 | Apparence | |
Numéro de catalogue | A845005 | Numéro MDL | MFCD26131254 |
Formule moléculaire | C18H27N3O3 | Masse moléculaire | 333.43 |
Point d'ébullition | Point de fusion | ||
Point de rupture | Densité | ||
Synonymes | (1S,3S,5S)-2-((S)-2-amino-2-((1r,3R,5R,7S)-3-hydroxyadamantan-1-yl)acetyl)-2-azabicyclo[3.1.0]hexane-3-carbonitrile hydrate | ||
Condition de stockage | Store in a tightly closed container,in a cool and dry place |
sécurité
Pictogramme SGH | |||
Mot de signal | Warning | Numéro UN | |
Mentions de danger | H302-H315-H319-H335 | Classe | |
Conseils de prudence | P261-P305+P351+P338 | Groupe d'emballage |
La description
Saxagliptin, also known as BMS-477118, is a new oral hypoglycemic (anti-diabetic drug) of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. Saxagliptin was approved in 2008 for the treatment of type 2 diabetes. Saxagliptin is a competitive DPP4 inhibitor that slows the inactivation of the incretin hormones, thereby increasing their bloodstream concentrations and reducing fasting and postprandial glucose concentrations in a glucose-dependent manner in patients with type 2 diabetes mellitus. |